DD:NYE-E.I. du Pont de Nemours and Company (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 80.71

Change

+1.14 (+1.43)%

Market Cap

USD 61.52B

Volume

2.12M

Analyst Target

USD 64.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

E.I. du Pont de Nemours & Co is a science and technology based company. It offers products and patents applications for agriculture, nutrition, electronics and communications, safety and protection, home and construction, transportation and others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-11 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
APD Air Products and Chemicals Inc

-5.73 (-1.99%)

USD 62.63B
LYB LyondellBasell Industries NV

-3.75 (-3.82%)

USD 31.67B
PPG PPG Industries Inc

-2.42 (-1.92%)

USD 29.76B
DLY DoubleLine Yield Opportunities..

+0.28 (+1.76%)

USD 27.84B
AVTR Avantor Inc

-0.90 (-3.40%)

USD 17.40B
ALB Albemarle Corp

-6.18 (-6.63%)

USD 10.22B
AXTA Axalta Coating Systems Ltd

-1.43 (-3.90%)

USD 8.08B
ESI Element Solutions Inc

-1.00 (-3.82%)

USD 6.42B
ASH Ashland Global Holdings Inc

-2.53 (-2.63%)

USD 4.69B
FUL H B Fuller Company

-2.85 (-3.39%)

USD 4.57B

ETFs Containing DD

BASE-B:CA Evolve Global Materials &.. 5.81 % 0.00 %

N/A

CAD 0.08B
ABEQ Absolute Core Strategy ET.. 5.21 % 0.00 %

-0.10 (0.00%)

USD 0.09B
TINT ProShares Smart Materials.. 4.73 % 0.00 %

-1.49 (0.00%)

USD 1.66M
FRFD:LSE Franklin Future of Food U.. 4.40 % 0.00 %

N/A

USD 2.46M
XDRV:CA 3.72 % 0.00 %

N/A

N/A
RSPM Invesco S&P 500® Equal.. 3.63 % 0.00 %

-0.91 (0.00%)

USD 0.29B
ZPDM:F SPDR S&P U.S. Materials S.. 3.40 % 0.00 %

-1.35 (0.00%)

USD 0.04B
ZPDM:XETRA SPDR S&P U.S. Materials S.. 3.40 % 0.00 %

-1.62 (0.00%)

USD 0.04B
SXLB:SW SPDR S&P U.S. Materials S.. 3.40 % 0.00 %

-1.13 (0.00%)

N/A
IUMS:LSE iShares S&P 500 Materials.. 3.27 % 0.00 %

-0.29 (0.00%)

USD 0.17B
SMOT 1.46 % 0.00 %

N/A

N/A
BIV Vanguard Intermediate-Ter.. 0.00 % 0.07 %

+0.88 (+0.00%)

N/A
BLV Vanguard Long-Term Bond I.. 0.00 % 0.07 %

+1.56 (+0.00%)

N/A
BSV Vanguard Short-Term Bond .. 0.00 % 0.07 %

+0.51 (+0.00%)

N/A
IBDO 0.00 % 0.10 %

N/A

N/A
JHMA 0.00 % 0.47 %

N/A

N/A
RFCI RiverFront Dynamic Core I.. 0.00 % 0.51 %

+0.18 (+0.00%)

USD 0.02B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-17.20 (0.00%)

N/A
SBM 0.00 % 0.95 %

N/A

N/A
SCHZ Schwab U.S. Aggregate Bon.. 0.00 % 0.04 %

+0.57 (+0.00%)

USD 7.94B
SMN ProShares UltraShort Basi.. 0.00 % 0.95 %

+0.30 (+0.00%)

N/A
VCIT Vanguard Intermediate-Ter.. 0.00 % 0.07 %

+0.69 (+0.00%)

USD 48.27B
VCLT Vanguard Long-Term Corpor.. 0.00 % 0.07 %

+1.13 (+0.00%)

USD 11.19B
VCSH Vanguard Short-Term Corpo.. 0.00 % 0.07 %

+0.39 (+0.00%)

USD 34.10B
SXLB:LSE SPDR S&P U.S. Materials S.. 0.00 % 0.00 %

-1.29 (0.00%)

N/A
UC97:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.28 (0.00%)

USD 0.20B
UC98:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-24.75 (0.00%)

USD 0.20B
XLPE:LSE Xtrackers LPX Private Equ.. 0.00 % 0.00 %

-603.00 (0.00%)

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

+0.37 (+0.00%)

USD 6.77B
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

+0.21 (+0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.91% 67% D+ 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.91% 58% F 46% F
Trailing 12 Months  
Capital Gain 10.26% 61% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.26% 59% D- 55% F
Trailing 5 Years  
Capital Gain 12.85% 46% F 55% F
Dividend Return 4.70% 17% F 15% F
Total Return 17.55% 41% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 10.84% 57% F 72% C
Dividend Return 11.91% 55% F 69% C-
Total Return 1.07% 30% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 31.33% 57% F 33% F
Risk Adjusted Return 38.03% 62% D 59% D-
Market Capitalization 61.52B 93% A 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.70 2% 7%
Price/Book Ratio 1.27 76% 60%
Price / Cash Flow Ratio 15.36 31% 24%
Price/Free Cash Flow Ratio 17.69 16% 18%
Management Effectiveness  
Return on Equity 1.73% 20% 31%
Return on Invested Capital 5.24% 31% 46%
Return on Assets 2.65% 24% 52%
Debt to Equity Ratio 31.84% 88% 71%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector